William Jones

BJ Jones is the Chief Commercial Officer, Migraine and Common Disease, at Biohaven Pharmaceuticals, where he is responsible for creating a vertically integrated commercial team from concept to deployment in ten months.

With over 25 years of commercial experience in the healthcare industry, BJ has held leadership roles of increasing responsibility at Takeda Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, and NitroMed. He has significant experience in mass market product launches and has successfully built and lead diverse commercial teams committed to addressing unmet patient needs across various therapeutic areas, including neuroscience, cardio-metabolic, respiratory, GI, and infectious disease.

Prior to joining the pharmaceutical industry, BJ served in the U.S. Air Force and earned the rank of Major. He provided threat assessments to NATO leadership as an Engineering Analyst in the Foreign Technology division and led cutting-edge research in the Artificial Intelligence in Training program as a Function Chief in the AF Human Systems Division.

He holds a BS in Human Factors Engineering from the U.S. Air Force Academy, an MS in Industrial Engineering from Texas A&M University, and an MBA from Stanford Graduate School of Business.